Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of protease inhibitors and antiviral drugs. Its stereochemistry enables selective interactions with biological targets, enhancing drug efficacy and metabolic stability. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to the trifluoromethyl group’s influence on lipophilicity and bioavailability. Also utilized in the preparation of enzyme inhibitors where the pyrrolidine scaffold supports conformational rigidity critical for target binding.